Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.
Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE.
Tuberculosis of the serous membrane lining the thoracic cavity and surrounding the lungs.
Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.
The thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid.
The production of adhesions between the parietal and visceral pleura. The procedure is used in the treatment of bronchopleural fistulas, malignant pleural effusions, and pneumothorax and often involves instillation of chemicals or other agents into the pleural space causing, in effect, a pleuritis that seals the air leak. (From Fishman, Pulmonary Diseases, 2d ed, p2233 & Dorland, 27th ed)
Paired but separate cavity within the THORACIC CAVITY. It consists of the space between the parietal and visceral PLEURA and normally contains a capillary layer of serous fluid that lubricates the pleural surfaces.
Inflammation of the middle ear with a clear pale yellow-colored transudate.
A collection of watery fluid in the pleural cavity. (Dorland, 27th ed)
Finely powdered native hydrous magnesium silicate. It is used as a dusting powder, either alone or with starch or boric acid, for medicinal and toilet preparations. It is also an excipient and filler for pills, tablets, and for dusting tablet molds. (From Merck Index, 11th ed)
The presence of chyle in the thoracic cavity. (Dorland, 27th ed)
A procedure in which fluid is withdrawn from a body cavity or organ via a trocar and cannula, needle, or other hollow instrument.
Suppurative inflammation of the pleural space.
'Pleural diseases' is a broad term referring to various medical conditions that affect the pleura, the thin, double-layered membrane surrounding the lungs, including inflammation (pleurisy), effusions (excess fluid buildup), thickening, or tumors, which may cause chest pain, coughing, and breathing difficulties.
The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.
Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
Presence of pus in a hollow organ or body cavity.
Endoscopic examination, therapy or surgery of the pleural cavity.
Surgical procedure involving the creation of an opening (stoma) into the chest cavity for drainage; used in the treatment of PLEURAL EFFUSION; PNEUMOTHORAX; HEMOTHORAX; and EMPYEMA.
A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
Accumulation or retention of free fluid within the peritoneal cavity.
Plastic tubes used for drainage of air or fluid from the pleural space. Their surgical insertion is called tube thoracostomy.
X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.
Tumors or cancer of the LUNG.
A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity.
Empyema due to MYCOBACTERIUM TUBERCULOSIS.
The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS.
An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA.
Infection with TREMATODA of the genus PARAGONIMUS.
Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.
An encapsulated accumulation of URINE in the retroperitoneal area. It has the appearance of a cyst (CYSTS). Urinoma is usually caused by URETERAL OBSTRUCTION, renal trauma or perforation of the renal collecting system.
Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.
Puncture and aspiration of fluid from the PERICARDIUM.
Infections of the lungs with parasites, most commonly by parasitic worms (HELMINTHS).
Presence of milky lymph (CHYLE) in the PERITONEAL CAVITY, with or without infection.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
An accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL.
Leakage and accumulation of CEREBROSPINAL FLUID in the subdural space which may be associated with an infectious process; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; INTRACRANIAL HYPOTENSION; and other conditions.
MYCOBACTERIUM infections of the lung.
Endoscopic surgery of the pleural cavity performed with visualization via video transmission.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Absence of air in the entire or part of a lung, such as an incompletely inflated neonate lung or a collapsed adult lung. Pulmonary atelectasis can be caused by airway obstruction, lung compression, fibrotic contraction, or other factors.
A genus of lung flukes of the family Troglotrematidae infecting humans and animals. This genus consists of several species one of which is PARAGONIMUS WESTERMANI, a common lung fluke in humans.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Infection of the lung often accompanied by inflammation.
Surgical excision (total or partial) of a portion of the pericardium. Pericardiotomy refers to incision of the pericardium.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Act of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
A type I keratin found associated with KERATIN-7 in ductal epithelia and gastrointestinal epithelia.
The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from THERAPEUTIC IRRIGATION in that the irrigate is removed within minutes, but the instillate is left in place.
Abnormal passage communicating with the PANCREAS.
Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. (Stedman, 26th ed)
Act of listening for sounds within the body.
A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.
Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and "classical" Kaposi sarcoma.
A malignant epithelial tumor with a glandular organization.
Ventilation of the middle ear in the treatment of secretory (serous) OTITIS MEDIA, usually by placement of tubes or grommets which pierce the TYMPANIC MEMBRANE.

Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions. (1/407)

We developed a sensitive and specific method for the detection of epithelial cancer cells in effusions with a two-stage molecular-based assay which combined enrichment for cancer cells by immunomagnetic bead selection and reverse transcriptase polymerase chain reaction (RT-PCR) detection of epithelial glycoprotein 2 (EGP-2) RNA. Preliminary experiments indicated that immunobead selection was essential to avoid occasional false-positive RT-PCR results, and this method detected ten breast cancer cells electively added to 10(7) cytologically negative effusion cells. We studied 110 cases of pleural (n = 68) and peritoneal (n = 42) effusions (30 from patients with known carcinoma and 80 from those without known carcinoma), and the results were compared with cytological findings. Of 18 effusions that were cytologically positive or suspicious for malignant cells, 17 (94%) were positive for EGP-2 RNA (the one negative sample was from a patient who recently received combination chemotherapy). Of 92 cytologically negative samples, 11 (12%) were positive for EGP-2, including six patients with a history of previous or current carcinoma. Our method appears to be highly specific and increases the sensitivity of detection of malignant cells; it may be a useful adjunct to routine cytopathological examination.  (+info)

Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions. (2/407)

Distinction between benign reactive mesothelial cells and metastatic breast adenocarcinoma cells in effusions from patients with a known prior history of breast cancer is not the easiest task in diagnostic pathology. Here, we report the usefulness of testing the expression of class I HLA antigens (HLA A, B, C) in this respect. Cytospins were prepared from effusions of patients without the history of breast cancer (5 cases) and from effusions of patients with infiltrating ductal carcinoma (11 cases). Three effusions from cancerous patients were not malignant cytologically. The expression of HLA-A, B, C, HLA-DR and beta2-microglobulin as well as the macrophage antigen, CD14, was evaluated by immunocytochemistry. In 10 of 11 effusions the cytologically malignant cells expressed very weak or undetectable HLA-A,B,C as compared to the mesothelial cells and macrophages. The paucity of expression of HLA-A, B, C was detectable in those 3 cases where a definitive cytological diagnosis of malignancy could not be established. In contrast, mesothelial cells and macrophages from all samples were uniformly and strongly positive for both HLA-A, B, C and beta2-microglobulin. We conclude that the paucity of HLA-I antigens provides a marker helpful in distinguishing metastatic breast carcinoma cells from reactive mesothelial cells in effusions.  (+info)

Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions. (3/407)

Tumor cells and associated stromal cells secrete matrix metalloproteinases (MMPs), contributing to invasion, angiogenesis, and metastasis. Batimastat (BB-94) is a broad-spectrum MMP inhibitor that causes resolution of ascites and/or tumor growth delay in animal models of breast, ovarian, and colorectal cancer. We recruited 18 patients with cytologically positive malignant pleural effusions into a Phase I study of intrapleural BB-94. Three patients received single doses of BB-94 at each dose level: 15, 30, 60, 105, 135, and 300 mg/m2. Two patients were retreated with a second course at 60 and 105 mg/m2. BB-94 was detectable in plasma 1 h after intrapleural administration, and peak levels of 20-200 ng/ml occurred after 4 h to 1 week. BB-94 persisted in the plasma for up to 12 weeks, at levels exceeding the IC50s for target MMPs. Peak values were higher, and persistence in the plasma was longer after higher doses of BB-94. The treatment was well tolerated. Toxic effects included low-grade fever for 24-48 h (6 of 18 patients, 33%) and reversible asymptomatic elevation of liver enzymes (8 patients, 44%). Toxicity seemed unrelated to BB-94 dose or plasma levels. Sixteen patients evaluable for response required significantly fewer pleural aspirations in the 3 months after BB-94 compared with the 3 months before. Seven patients (44%) required no further pleural aspiration until death/last follow-up. After 1 month, patients treated with 60-300 mg/m2 BB-94 had significantly better dyspnea scores, indicating improved exercise tolerance, compared with baseline scores the day after BB-94. The maximum tolerated intrapleural dose remains to be defined, but it is clear that intrapleural BB-94 is well tolerated, with evidence of local activity.  (+info)

High pleural fluid hyaluronan concentrations in rheumatoid arthritis. (4/407)

Previous studies have shown that high pleural fluid (Pf) hyaluronan (HYA) concentrations may be due not only to malignant mesothelioma but also to inflammatory diseases. The objective of this study was to evaluate Pf-HYA in various nonmalignant inflammatory pleural disorders. A radiometric assay was used to determine HYA in Pf and serum (S) of 126 patients, 12 of whom had rheumatoid arthritis (RA), 22 tuberculosis, 22 pneumonia, 41 lung cancer, 10 malignant mesothelioma and 19 congestive heart failure. Pf-HYA values were correlated with values for Pf-tumour necrosis factor (TNF)-alpha and Pf-interleukin (IL)-1beta, as determined by radioimmunoassay. The highest median Pf-HYA (125.6 mg x L(-1), range 0.04-386.5 mg x L(-1)) occurred in patients with malignant mesothelioma. Among patients with nonmalignant inflammatory diseases, significantly higher median Pf-HYA were observed in those with rheumatoid arthritis (64.2 mg x L(-1), range 25.8-106.9 mg x L(-1)) than in those with tuberculosis (25.5 mg x L(-1), range 14.9-57.1 mg x L(-1), p<0.0005) or pneumonia (20.9 mg x L(-1), range 9.5-129.4 mg x L(-1), p<0.005). There was no correlation between Pf-HYA and S-HYA. Pf-HYA correlated positively with Pf-TNF-alpha (r=0.62) and Pf-IL-1beta (r=0.52). High pleural fluid hyaluronan occurs not only in malignant mesothelioma, but also in certain nonmalignant inflammatory diseases, especially rheumatoid arthritis. One explanation for the increase in pleural fluid hyaluronan may be local production of proinflammatory cytokines, such as tumour necrosis factor-alpha and interleukin-1beta.  (+info)

Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. (5/407)

The aim of this study was to assess the biological characteristics of four new malignant mesothelioma (MM) cell lines. Since simian virus (SV)40 sequences have been recently detected in MM, SV40 large T antigen (Tag) expression was also analysed. MM cell lines were characterized by morphological, ultrastructural and cytogenetic analysis. Expression of Tag and of relevant MM markers was studied by immunocytochemistry, surface antigens by indirect immunofluorescence and immunomodulating cytokines by enzyme-linked immunosorbent assay (ELISA). The four MM cell lines, established from pleural effusions, showed a slow proliferation rate and pleomorphic changes during culture. Cell lines expressed vimentin, cytokeratins 8 and 18, and the mesothelial antigen recognized by HBME-1 monoclonal antibody, but not carcinoembryonic antigen. Surface human leukocyte antigen (HLA)-class I and intercellular adhesion molecule (ICAM)-1 molecules were present on all the cell lines. While HLA class II and CD86 were constitutively undetectable, HLA-class II was present after interferon (IFN)-gamma stimulation. All cell lines displayed abnormal karyotypes with chromosome 6 abnormalities. Transforming growth factor (TGF)-beta2 and interleukin (IL)-6 were constitutively secreted, while tumour necrosis factor (TNF)-alpha was secreted only in response to lipopolysaccharide. Intranuclear Tag was expressed in two cell lines. The persistence of large T antigen with human leukocyte antigen class I and intercellular adhesion molecule-1 positivity may point to large T antigen as a target for cytotoxic T-lymphocyte-based immunotherapy in some malignant mesothelioma patients.  (+info)

Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells. (6/407)

Sialomucin complex (SMC) is a large heterodimeric glycoprotein complex composed of a mucin subunit ascites sialoglycoprotein-1 and a transmembrane subunit ascites sialoglycoprotein-2. It is a rat homologue of human mucin gene MUC4 and is abundantly expressed on the cell surface of highly metastatic ascites 13762 rat mammary adenocarcinoma cells. Because of their extended and rigid structures, mucin-type glycoproteins are suggested to have suppressing effects on cell-cell and cell-matrix interactions. During the metastatic process, these effects presumably cause tumor cell detachment from the primary tumor mass and facilitate escape of the tumor cells from immunosurveillance. Analyses of human breast cancer cells in solid tumors and tumor effusions showed that the more aggressive cells in effusions are stained with polyclonal antibodies against SMC more frequently than cells in solid tumors, suggesting a role for MUC4/SMC in tumor progression and metastasis. Previously, we generated recombinant cDNAs for SMC that vary in the number of mucin repeats to study the putative functions of SMC in tumor metastasis. These cDNAs were transfected into human cancer cell lines and tested for the effect of the expression of this gene. Here, using a tetracycline-responsive inducible expression system, we demonstrate that overexpression of SMC masks the surface antigens on target tumor cells and effectively suppresses tumor cell killing by cytotoxic lymphocytes. This effect results from the ability of SMC to block killer cell binding to the tumor cells and is dependent on both overexpression of the mucin and the number of mucin repeats in the expressed SMC. These results provide an explanation for the proposed role of SMC/MUC4 in tumor progression.  (+info)

Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion. (7/407)

The current prospective randomized study was designed to compare the effects of intracavitary (i.c.) chemotherapy vs immunotherapy vs immunochemotherapy for malignant effusion. Between 1992 and 1995, a total of 42 patients with malignant effusion were registered, and 41 patients were eligible for statistical analysis. The primary diseases of the eligible patients included 27 gastric, four colorectal, four pancreatic, three lung, two liver and one oesophageal cancers. The patients with malignant effusion were randomly assigned into one of three i.c. therapeutic regimens: chemotherapy alone with weekly injection of anticancer agents (ACAs: cisplatin, mitomycin-C, adriamycin, etc.) (Group A, n = 13); immunotherapy alone with weekly injection of streptococcal preparation OK-432 (Group B, n = 14); or immunochemotherapy with ACAs and OK-432 (Group C, n = 14). The response of the effusion, patient survival and the kinetics of cytokines in the effusion were compared. There were no differences in the patients' backgrounds. The side-effects of the regimens included pain, anorexia, fever, leucopenia and anaemia and there were no differences in their incidence among the three groups. One patient died after cisplatin (CDDP) administration in Group A. Cytologic examination revealed that tumour cells in the effusion disappeared in 23% of Group A cases, 36% of Group B cases and 36% of Group C cases. The malignant effusion did not disappear in any of the Group A cases; however, the effusion disappeared in 29% of Group B cases and 43% of Group C cases (P = 0.03, Group A vs Group C). Furthermore, the 50% survival period was 1.6 months for Group A, 2.4 months for Group B and 3.5 months for Group C. The 6-month survival rate was 7% for Group A, 6% for Group B and 34% for Group C, and the 1-year survival rate was 0%, 0% and 17% respectively (P = 0.048, Group A vs Group C by the log-rank test). The analysis of the cytokine kinetics revealed a prominent increase in the level of interleukin-6 in the effusion in Group C. These results suggest that i.c. immunochemotherapy with OK-432 and ACAs may be more beneficial than i.c. chemotherapy alone or immunotherapy alone.  (+info)

Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. (8/407)

BACKGROUND: Investigation and management of pleural effusions is an important clinical problem yet the pathogenesis of pleural fluid accumulation is poorly understood. Vascular endothelial growth factor (VEGF) is a potent inducer of capillary permeability that is produced by both malignant and inflammatory cells. A study was undertaken to determine whether VEGF has a potential pathogenic role in the development of pleural effusions and whether VEGF receptors are present on human pleural mesothelial cells. METHODS: Normal and inflamed pleura were examined immunohistochemically for the presence of FLT-1 (the fms-like tyrosine kinase receptor of VEGF). VEGF levels were measured by ELISA in 78 consecutive patients presenting with undiagnosed unilateral pleural effusions and the levels were correlated with the aetiology of the effusions. RESULTS: Immunohistochemical staining of normal and diseased pleura demonstrated the presence of the FLT-1 VEGF receptor on human mesothelial cells. Median VEGF levels were 2500 pg/ml in the malignant group and 305 pg/ml in the non-malignant group (median difference 1397.5 pg/ml (95% CI 851 to 2693), p<0.005). Median VEGF levels varied according to tumour histology. VEGF levels were also significantly raised compared with transudates (median 36.5 pg/ml) in empyema (4651 pg/ml (95% CI 833 to 10 000), p<0.001) and parainfectious effusions (360 pg/ml (95% CI 46 to 597), p<0.005). CONCLUSIONS: This first report of VEGF receptors on pleural mesothelial cells has indicated a potential mechanism for the biological activity of VEGF on pleural tissue. VEGF levels are raised in the majority of exudative effusions, implying a pathogenic role for this molecule in the development of pleural effusions.  (+info)

Pleural effusion is a medical condition characterized by the abnormal accumulation of fluid in the pleural space, which is the thin, fluid-filled space that surrounds the lungs and lines the inside of the chest wall. This space typically contains a small amount of fluid to allow for smooth movement of the lungs during breathing. However, when an excessive amount of fluid accumulates, it can cause symptoms such as shortness of breath, coughing, and chest pain.

Pleural effusions can be caused by various underlying medical conditions, including pneumonia, heart failure, cancer, pulmonary embolism, and autoimmune disorders. The fluid that accumulates in the pleural space can be transudative or exudative, depending on the cause of the effusion. Transudative effusions are caused by increased pressure in the blood vessels or decreased protein levels in the blood, while exudative effusions are caused by inflammation, infection, or cancer.

Diagnosis of pleural effusion typically involves a physical examination, chest X-ray, and analysis of the fluid in the pleural space. Treatment depends on the underlying cause of the effusion and may include medications, drainage of the fluid, or surgery.

Malignant pleural effusion is a medical condition characterized by the abnormal accumulation of fluid in the pleural space (the area between the lungs and the chest wall) due to the spread of malignant (cancerous) cells from a primary tumor located elsewhere in the body. This type of effusion is typically associated with advanced-stage cancer, and it can cause symptoms such as shortness of breath, coughing, and chest pain. The presence of malignant pleural effusion often indicates a poor prognosis, and treatment is generally focused on palliating symptoms and improving quality of life.

Pericardial effusion is an abnormal accumulation of fluid in the pericardial space, which is the potential space between the two layers of the pericardium - the fibrous and serous layers. The pericardium is a sac that surrounds the heart to provide protection and lubrication for the heart's movement during each heartbeat. Normally, there is only a small amount of fluid (5-15 mL) in this space to ensure smooth motion of the heart. However, when an excessive amount of fluid accumulates, it can cause increased pressure on the heart, leading to various complications such as decreased cardiac output and even cardiac tamponade, a life-threatening condition that requires immediate medical attention.

Pericardial effusion may result from several causes, including infections (viral, bacterial, or fungal), inflammatory conditions (such as rheumatoid arthritis, lupus, or cancer), trauma, heart surgery, kidney failure, or iatrogenic causes. The symptoms of pericardial effusion can vary depending on the rate and amount of fluid accumulation. Slowly developing effusions may not cause any symptoms, while rapid accumulations can lead to chest pain, shortness of breath, cough, palpitations, or even hypotension (low blood pressure). Diagnosis is usually confirmed through imaging techniques such as echocardiography, CT scan, or MRI. Treatment depends on the underlying cause and severity of the effusion, ranging from close monitoring to drainage procedures or medications to address the root cause.

Pleural Tuberculosis is a form of extrapulmonary tuberculosis (EPTB) that involves the infection and inflammation of the pleura, which are the thin membranes that surround the lungs and line the inside of the chest cavity. This condition is caused by the Mycobacterium tuberculosis bacterium, which can spread through the air when an infected person coughs, sneezes, or talks.

In pleural tuberculosis, the bacteria reach the pleura either through direct extension from a nearby lung infection or via bloodstream dissemination. The infection can cause the pleura to become inflamed and produce excess fluid, leading to pleural effusion. This accumulation of fluid in the pleural space can cause chest pain, coughing, and difficulty breathing.

Diagnosis of pleural tuberculosis typically involves a combination of medical history, physical examination, imaging studies such as chest X-rays or CT scans, and laboratory tests such as acid-fast bacilli (AFB) smear microscopy, culture, and nucleic acid amplification tests (NAATs) to detect the presence of M. tuberculosis in the pleural fluid or tissue samples.

Treatment of pleural tuberculosis typically involves a standard course of anti-tuberculosis therapy (ATT), which includes a combination of multiple antibiotics such as isoniazid, rifampin, ethambutol, and pyrazinamide. The duration of treatment may vary depending on the severity of the infection and the patient's response to therapy. In some cases, surgical intervention may be necessary to drain the pleural effusion or remove the infected pleura.

Exudates and transudates are two types of bodily fluids that can accumulate in various body cavities or tissues as a result of injury, inflammation, or other medical conditions. Here are the medical definitions:

1. Exudates: These are fluids that accumulate due to an active inflammatory process. Exudates contain high levels of protein, white blood cells (such as neutrophils and macrophages), and sometimes other cells like red blood cells or cellular debris. They can be yellow, green, or brown in color and may have a foul odor due to the presence of dead cells and bacteria. Exudates are often seen in conditions such as abscesses, pneumonia, pleurisy, or wound infections.

Examples of exudative fluids include pus, purulent discharge, or inflammatory effusions.

2. Transudates: These are fluids that accumulate due to increased hydrostatic pressure or decreased oncotic pressure within the blood vessels. Transudates contain low levels of protein and cells compared to exudates. They are typically clear and pale yellow in color, with no odor. Transudates can be found in conditions such as congestive heart failure, liver cirrhosis, or nephrotic syndrome.

Examples of transudative fluids include ascites, pleural effusions, or pericardial effusions.

It is essential to differentiate between exudates and transudates because their underlying causes and treatment approaches may differ significantly. Medical professionals often use various tests, such as fluid analysis, to determine whether a fluid sample is an exudate or transudate.

The pleura is the medical term for the double-layered serous membrane that surrounds the lungs and lines the inside of the chest cavity. The two layers of the pleura are called the parietal pleura, which lines the chest cavity, and the visceral pleura, which covers the surface of the lungs.

The space between these two layers is called the pleural cavity, which contains a small amount of lubricating fluid that allows the lungs to move smoothly within the chest during breathing. The main function of the pleura is to protect the lungs and facilitate their movement during respiration.

Pleurodesis is a medical procedure that involves the intentional inflammation and subsequent fusion of the pleural surfaces, which are the thin layers of tissue that separate the lungs from the chest wall. This procedure is typically performed to prevent the recurrence of pneumothorax (a collapsed lung) or pleural effusions (abnormal fluid accumulation in the pleural space).

During the pleurodesis procedure, an irritant such as talc, doxycycline, or silver nitrate is introduced into the pleural space. This causes an inflammatory response, leading to the formation of adhesions between the visceral and parietal pleura. These adhesions obliterate the potential space between the pleural layers, preventing the accumulation of air or fluid within that space.

There are two primary approaches to performing pleurodesis: thoracoscopic (using a video-assisted thoracoscopic surgery or VATS) and chemical (instilling a sclerosing agent through a chest tube). Both methods aim to achieve the same goal of creating adhesions between the pleural layers.

It is essential to note that, while pleurodesis can be an effective treatment for preventing recurrent pneumothorax or pleural effusions, it is not without risks and potential complications. These may include pain, fever, infection, empyema (pus in the pleural space), or acute respiratory distress syndrome (ARDS). Patients should discuss these risks with their healthcare provider before undergoing the procedure.

The pleural cavity is the potential space between the visceral and parietal pleura, which are the two membranes that surround the lungs. The visceral pleura covers the outside of the lungs, while the parietal pleura lines the inside of the chest wall. Under normal conditions, these two layers are in contact with each other, and the space between them is virtually nonexistent. However, when air, fluid or inflammation accumulates within this space, it results in the formation of a pleural effusion, which can cause discomfort and difficulty breathing.

Otitis media with effusion (OME), also known as serous otitis media or glue ear, is a medical condition characterized by the presence of fluid in the middle ear without signs or symptoms of acute ear infection. The fluid accumulation occurs due to the dysfunction of the Eustachian tube, which results in negative pressure and subsequent accumulation of sterile fluid within the middle ear space.

OME can lead to hearing difficulties, especially in children, as the fluid buildup impairs sound conduction through the ossicles in the middle ear. Symptoms may include mild hearing loss, tinnitus (ringing in the ears), and a sensation of fullness or pressure in the affected ear. In some cases, OME can resolve on its own within a few weeks or months; however, persistent cases might require medical intervention, such as placement of tympanostomy tubes (ear tubes) to drain the fluid and restore hearing.

Hydrothorax is a medical term that refers to the abnormal accumulation of serous fluid in the pleural space, which is the potential space between the lungs and the chest wall. This condition often results from various underlying pathological processes such as liver cirrhosis, heart failure, or kidney disease, where there is an imbalance in the body's fluid regulation leading to the accumulation of fluid in the pleural cavity. The presence of hydrothorax can cause respiratory distress and other symptoms related to lung function impairment.

Talc is a mineral composed of hydrated magnesium silicate with the chemical formula H2Mg3(SiO3)4 or Mg3Si4O10(OH)2. It is widely used in various industries including pharmaceuticals and cosmetics due to its softness, lubricity, and ability to absorb moisture. In medical contexts, talc is often found in powdered products used for personal hygiene or as a drying agent in medical dressings. However, it should be noted that the use of talcum powder in the genital area has been linked to an increased risk of ovarian cancer, although the overall evidence remains controversial.

Chylothorax is a medical condition characterized by the accumulation of lymphatic fluid called chyle in the pleural space, which is the space between the lungs and the chest wall. Chyle is a milky-white fluid that contains nutrients, electrolytes, and immune cells, and it is normally transported through the thoracic duct to the bloodstream.

Chylothorax can occur due to various reasons, such as trauma, surgery, tumors, or congenital abnormalities that disrupt the normal flow of chyle. As a result, chyle leaks into the pleural space, causing symptoms such as cough, chest pain, difficulty breathing, and fever.

The diagnosis of chylothorax is usually made through imaging studies such as chest X-ray or CT scan, and confirmed by analyzing the fluid for the presence of chylomicrons, which are lipid particles found in chyle. The treatment options for chylothorax include dietary modifications, such as a low-fat diet with medium-chain triglycerides, chest tube drainage, and surgical interventions such as thoracic duct ligation or pleurodesis.

Paracentesis is a medical procedure in which a thin needle or catheter is inserted through the abdominal wall to remove excess fluid from the peritoneal cavity. This procedure is also known as abdominal tap or paracentesis aspiration. The fluid removed, called ascites, can be analyzed for infection, malignant cells, or other signs of disease. Paracentesis may be performed to relieve symptoms caused by the buildup of excess fluid in the abdomen, such as pain, difficulty breathing, or loss of appetite. It is commonly used to diagnose and manage conditions such as liver cirrhosis, cancer, heart failure, and kidney failure.

Empyema is a collection of pus in a body cavity. Pleural empyema refers to the presence of pus in the pleural space, which is the thin fluid-filled space that surrounds the lungs. This condition usually develops as a complication of pneumonia or lung infection, and it can cause symptoms such as chest pain, cough, fever, and difficulty breathing. Treatment typically involves antibiotics to treat the underlying infection, as well as drainage of the pus from the pleural space through procedures such as thoracentesis or chest tube placement. In severe cases, surgery may be necessary to remove the infected pleura and prevent recurrence.

Pleural diseases refer to conditions that affect the pleura, which is the thin, double-layered membrane that surrounds the lungs and lines the inside of the chest wall. The space between these two layers contains a small amount of fluid that helps the lungs move smoothly during breathing. Pleural diseases can cause inflammation, infection, or abnormal collections of fluid in the pleural space, leading to symptoms such as chest pain, cough, and difficulty breathing.

Some common examples of pleural diseases include:

1. Pleurisy: Inflammation of the pleura that causes sharp chest pain, often worsened by breathing or coughing.
2. Pleural effusion: An abnormal accumulation of fluid in the pleural space, which can be caused by various underlying conditions such as heart failure, pneumonia, cancer, or autoimmune disorders.
3. Empyema: A collection of pus in the pleural space, usually resulting from a bacterial infection.
4. Pleural thickening: Scarring and hardening of the pleura, which can restrict lung function and cause breathlessness.
5. Mesothelioma: A rare form of cancer that affects the pleura, often caused by exposure to asbestos.
6. Pneumothorax: A collection of air in the pleural space, which can result from trauma or a rupture of the lung tissue.

Proper diagnosis and treatment of pleural diseases require a thorough evaluation by a healthcare professional, often involving imaging tests such as chest X-rays or CT scans, as well as fluid analysis or biopsy if necessary.

Drainage, in medical terms, refers to the removal of excess fluid or accumulated collections of fluids from various body parts or spaces. This is typically accomplished through the use of medical devices such as catheters, tubes, or drains. The purpose of drainage can be to prevent the buildup of fluids that may cause discomfort, infection, or other complications, or to treat existing collections of fluid such as abscesses, hematomas, or pleural effusions. Drainage may also be used as a diagnostic tool to analyze the type and composition of the fluid being removed.

Pleurisy is a medical condition characterized by inflammation of the pleura, which are the thin membranes that surround the lungs and line the inside of the chest cavity. The pleura normally produce a small amount of lubricating fluid that allows for smooth movement of the lungs during breathing. However, when they become inflamed (a condition known as pleuritis), this can cause pain and difficulty breathing.

The symptoms of pleurisy may include sharp chest pain that worsens with deep breathing or coughing, shortness of breath, cough, fever, and muscle aches. The pain may be localized to one area of the chest or may radiate to other areas such as the shoulders or back.

Pleurisy can have many different causes, including bacterial or viral infections, autoimmune disorders, pulmonary embolism (a blood clot that travels to the lungs), and certain medications or chemicals. Treatment typically involves addressing the underlying cause of the inflammation, as well as managing symptoms such as pain and breathing difficulties with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids. In some cases, more invasive treatments such as thoracentesis (removal of fluid from the chest cavity) may be necessary.

Pleural neoplasms refer to abnormal growths or tumors that develop in the pleura, which is the thin, double layered membrane that surrounds the lungs and lines the inside of the chest wall. These neoplasms can be benign (non-cancerous) or malignant (cancerous).

Malignant pleural neoplasms are often associated with lung cancer, mesothelioma, or metastasis from other types of cancer. They can cause symptoms such as chest pain, cough, shortness of breath, and weight loss. Diagnosis typically involves imaging tests like X-rays or CT scans, followed by biopsy to confirm the type of tumor. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Empyema is a medical condition characterized by the accumulation of pus in a body cavity, most commonly in the pleural space surrounding the lungs. It is usually caused by a bacterial infection that spreads from the lung tissue to the pleural space. The buildup of pus can cause chest pain, cough, fever, and difficulty breathing. Empyema can be a complication of pneumonia or other respiratory infections, and it may require treatment with antibiotics, drainage of the pus, and sometimes surgery.

Thoracoscopy is a surgical procedure in which a thoracoscope, a type of endoscope, is inserted through a small incision between the ribs to examine the lungs and pleural space (the space surrounding the lungs). It allows the surgeon to directly view the chest cavity, take biopsies, and perform various operations. This procedure is often used in the diagnosis and treatment of pleural effusions, lung cancer, and other chest conditions.

Thoracostomy is a surgical procedure that involves the creation of an opening into the chest cavity to relieve excessive pressure, drain fluid or air accumulation, or provide access for surgery. It is commonly performed to treat conditions such as pneumothorax (collapsed lung), hemothorax (blood in the chest cavity), pleural effusion (excess fluid in the pleural space), and empyema (pus in the pleural space).

During a thoracostomy, a healthcare professional makes an incision on the chest wall and inserts a tube called a thoracostomy tube or chest tube. The tube is connected to a drainage system that helps remove the air, fluid, or blood from the chest cavity. This procedure can be performed as an emergency treatment or as a planned surgical intervention.

The medical definition of thoracostomy includes the following key components:

1. A surgical procedure
2. Involving the creation of an opening
3. Into the chest cavity (thorax)
4. To relieve pressure, drain fluids or air, or provide access for surgery
5. Often performed with the insertion of a thoracostomy tube or chest tube
6. Used to treat various conditions related to the pleural space and lungs

Mesothelioma is a rare and aggressive form of cancer that develops in the mesothelial cells, which are the thin layers of tissue that cover many of the internal organs. The most common site for mesothelioma to occur is in the pleura, the membrane that surrounds the lungs. This type is called pleural mesothelioma. Other types include peritoneal mesothelioma (which occurs in the lining of the abdominal cavity) and pericardial mesothelioma (which occurs in the lining around the heart).

Mesothelioma is almost always caused by exposure to asbestos, a group of naturally occurring minerals that were widely used in construction, insulation, and other industries because of their heat resistance and insulating properties. When asbestos fibers are inhaled or ingested, they can become lodged in the mesothelium, leading to inflammation, scarring, and eventually cancerous changes in the cells.

The symptoms of mesothelioma can take many years to develop after exposure to asbestos, and they may include chest pain, coughing, shortness of breath, fatigue, and weight loss. Treatment options for mesothelioma depend on the stage and location of the cancer, but may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. Unfortunately, the prognosis for mesothelioma is often poor, with a median survival time of around 12-18 months after diagnosis.

Ascites is an abnormal accumulation of fluid in the peritoneal cavity, which is the space between the lining of the abdominal wall and the organs within it. This buildup of fluid can cause the belly to swell and become distended. Ascites can be caused by various medical conditions, including liver cirrhosis, cancer, heart failure, and kidney disease. The accumulation of fluid in the peritoneal cavity can lead to complications such as infection, reduced mobility, and difficulty breathing. Treatment for ascites depends on the underlying cause and may include diuretics, paracentesis (a procedure to remove excess fluid from the abdomen), or treatment of the underlying medical condition.

Chest tubes are medical devices that are inserted into the chest cavity to drain fluid, air, or blood. They are typically used to treat conditions such as pneumothorax (collapsed lung), hemothorax (blood in the chest cavity), pleural effusion (excess fluid in the chest cavity), and chylothorax (milky fluid in the chest cavity).

Chest tubes are usually inserted between the ribs and directed into the chest cavity, allowing for drainage of the affected area. The tubes are connected to a collection system that creates negative pressure, which helps to remove the air or fluid from the chest cavity.

The size and number of chest tubes used may vary depending on the severity and location of the condition being treated. Chest tubes are typically removed once the underlying condition has been resolved and the drainage has decreased to a minimal amount.

Thoracic radiography is a type of diagnostic imaging that involves using X-rays to produce images of the chest, including the lungs, heart, bronchi, great vessels, and the bones of the spine and chest wall. It is a commonly used tool in the diagnosis and management of various respiratory, cardiovascular, and thoracic disorders such as pneumonia, lung cancer, heart failure, and rib fractures.

During the procedure, the patient is positioned between an X-ray machine and a cassette containing a film or digital detector. The X-ray beam is directed at the chest, and the resulting image is captured on the film or detector. The images produced can help identify any abnormalities in the structure or function of the organs within the chest.

Thoracic radiography may be performed as a routine screening test for certain conditions, such as lung cancer, or it may be ordered when a patient presents with symptoms suggestive of a respiratory or cardiovascular disorder. It is a safe and non-invasive procedure that can provide valuable information to help guide clinical decision making and improve patient outcomes.

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that typically presents as an effusion (accumulation of fluid) in the pleural, pericardial, or peritoneal cavities without a detectable tumor mass. It is strongly associated with the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) and often occurs in people with weakened immune systems, such as those with HIV/AIDS. The malignant cells in PEL are typically large B-cells that secrete fluid, leading to the formation of effusions. This type of lymphoma is aggressive and has a poor prognosis.

Lung neoplasms refer to abnormal growths or tumors in the lung tissue. These tumors can be benign (non-cancerous) or malignant (cancerous). Malignant lung neoplasms are further classified into two main types: small cell lung carcinoma and non-small cell lung carcinoma. Lung neoplasms can cause symptoms such as cough, chest pain, shortness of breath, and weight loss. They are often caused by smoking or exposure to secondhand smoke, but can also occur due to genetic factors, radiation exposure, and other environmental carcinogens. Early detection and treatment of lung neoplasms is crucial for improving outcomes and survival rates.

Picibanil is not a commonly used medical term, and it may be more familiar as the brand name for a specific preparation of Group A Streptococcus OK-432. It is an immunotherapeutic agent that has been used in Japan for the treatment of certain types of cancer, such as nasopharyngeal carcinoma and soft tissue sarcoma.

Group A Streptococcus OK-432 is a weakened form of a bacterium that causes strep throat. When administered, it stimulates the immune system to produce cytokines, which are substances that help regulate the immune response. This can enhance the body's ability to fight off cancer cells and potentially slow or stop tumor growth.

It is important to note that Picibanil/OK-432 is not approved for use in the United States and its effectiveness as a cancer treatment has not been extensively studied outside of Japan.

Tuberculous empyema is a specific type of empyema, which is a collection of pus in the pleural space (the space between the lungs and the chest wall). It is caused by the Mycobacterium tuberculosis bacterium, which is the same bacterium that causes tuberculosis (TB) of the lungs.

In tuberculous empyema, the bacteria spread from the lungs to the pleural space, where they cause an infection and inflammation. This can lead to the accumulation of pus and the development of a chronic empyema. Symptoms may include chest pain, cough, fever, and difficulty breathing. Treatment typically involves a prolonged course of multiple antibiotics to kill the bacteria, as well as drainage of the pus from the pleural space. In some cases, surgery may be necessary to remove the infected tissue and prevent recurrence.

Meigs syndrome is a rare medical condition characterized by the combination of ovarian tumor (most commonly fibroma or thecoma), ascites (abnormal accumulation of fluid in the abdominal cavity), and pleural effusion (fluid accumulation around the lungs). The hallmark feature of this syndrome is that all these symptoms resolve after the removal of the ovarian tumor.

It's important to note that not all women with ovarian tumors will develop Meigs syndrome, and its exact cause remains unclear. It primarily affects middle-aged women and is typically diagnosed through imaging tests (such as ultrasound or CT scan) and the exclusion of other possible causes of ascites and pleural effusion.

After surgical removal of the ovarian tumor, the ascites and pleural effusion usually resolve on their own within a few months. Meigs syndrome is not considered a malignant condition, but regular follow-ups are necessary to monitor for any potential recurrence of the ovarian tumor or development of other health issues.

Adenosine Deaminase (ADA) is an enzyme that plays a crucial role in the immune system by helping to regulate the levels of certain chemicals called purines within cells. Specifically, ADA helps to break down adenosine, a type of purine, into another compound called inosine. This enzyme is found in all tissues of the body, but it is especially active in the immune system's white blood cells, where it helps to support their growth, development, and function.

ADA deficiency is a rare genetic disorder that can lead to severe combined immunodeficiency (SCID), a condition in which babies are born with little or no functional immune system. This makes them extremely vulnerable to infections, which can be life-threatening. ADA deficiency can be treated with enzyme replacement therapy, bone marrow transplantation, or gene therapy.

Paragonimiasis is a tropical pulmonary disease caused by the infection of Paragonimus species, a type of lung fluke. The disease cycle begins when humans consume undercooked or raw crustaceans (such as crabs or crayfish) that contain the larval form of the parasite. Once ingested, the larvae penetrate the intestinal wall and migrate to the lungs, where they develop into adult worms and produce eggs.

Symptoms of paragonimiasis can vary depending on the severity of the infection and the location of the worms in the body. Common symptoms include coughing up blood (hemoptysis), chest pain, difficulty breathing, fever, and diarrhea. In some cases, the parasites may migrate to other organs such as the brain or liver, causing additional complications.

Diagnosis of paragonimiasis typically involves a combination of clinical symptoms, imaging studies (such as chest X-rays), and laboratory tests (such as stool or sputum analysis for parasite eggs). Treatment usually involves administration of antihelminthic drugs such as praziquantel or triclabendazole to kill the adult worms. Preventive measures include cooking crustaceans thoroughly before consumption, avoiding raw or undercooked seafood, and practicing good personal hygiene.

Cardiac tamponade is a serious medical condition that occurs when there is excessive fluid or blood accumulation in the pericardial sac, which surrounds the heart. This accumulation puts pressure on the heart, preventing it from filling properly and reducing its ability to pump blood effectively. As a result, cardiac output decreases, leading to symptoms such as low blood pressure, shortness of breath, chest pain, and a rapid pulse. If left untreated, cardiac tamponade can be life-threatening, requiring emergency medical intervention to drain the fluid and relieve the pressure on the heart.

A urinoma is a medical term that refers to a collection or pooling of urine in a confined space or area within the body, usually due to a leakage from the urinary system. This condition most commonly occurs as a result of trauma, surgery, or injury to the urinary tract, such as the kidneys or ureters.

The accumulation of urine in the surrounding tissues can lead to inflammation, infection, and other complications if left untreated. Symptoms of a urinoma may include abdominal or back pain, fever, nausea, vomiting, and decreased urine output. Diagnosis is typically made through imaging tests such as CT scans or ultrasounds, and treatment may involve surgical repair of the damaged urinary tract, placement of a catheter to drain the urinoma, or administration of antibiotics to prevent infection.

Pericarditis is a medical condition characterized by inflammation of the pericardium, which is the thin sac-like membrane that surrounds the heart and contains serous fluid to reduce friction during heartbeats. The inflammation can cause symptoms such as chest pain, shortness of breath, and sometimes fever.

The pericardium has two layers: the visceral pericardium, which is tightly adhered to the heart's surface, and the parietal pericardium, which lines the inner surface of the chest cavity. Normally, there is a small amount of fluid between these two layers, allowing for smooth movement of the heart within the chest cavity.

In pericarditis, the inflammation causes the pericardial layers to become irritated and swollen, leading to an accumulation of excess fluid in the pericardial space. This can result in a condition called pericardial effusion, which can further complicate the situation by putting pressure on the heart and impairing its function.

Pericarditis may be caused by various factors, including viral or bacterial infections, autoimmune disorders, heart attacks, trauma, or cancer. Treatment typically involves addressing the underlying cause, managing symptoms, and reducing inflammation with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids. In severe cases, pericardiocentesis (removal of excess fluid from the pericardial space) or surgical intervention may be necessary.

Pericardiocentesis is a medical procedure where a needle or a catheter is inserted into the pericardial sac, the thin fluid-filled space surrounding the heart, to remove excess fluids or air that has accumulated. This buildup can put pressure on the heart and impede its function, leading to various cardiac symptoms such as chest pain, shortness of breath, and palpitations. The procedure is often guided by echocardiography or fluoroscopy to ensure proper placement and minimize risks. Pericardiocentesis may be performed as an emergency treatment or a scheduled intervention, depending on the patient's condition.

Parasitic lung diseases refer to conditions caused by infection of the lungs by parasites. These are small organisms that live on or in a host organism and derive their sustenance at the expense of the host. Parasitic lung diseases can be caused by various types of parasites, including helminths (worms) and protozoa.

Examples of parasitic lung diseases include:

1. Pulmonary echinococcosis (hydatid disease): This is a rare infection caused by the larval stage of the tapeworm Echinococcus granulosus. The larvae form cysts in various organs, including the lungs.
2. Paragonimiasis: This is a food-borne lung fluke infection caused by Paragonimus westermani and other species. Humans become infected by eating raw or undercooked crustaceans (such as crabs or crayfish) that contain the larval stage of the parasite.
3. Toxocariasis: This is a soil-transmitted helminth infection caused by the roundworm Toxocara canis or T. cati, which are found in the intestines of dogs and cats. Humans become infected through accidental ingestion of contaminated soil, undercooked meat, or through contact with an infected animal's feces. Although the primary site of infection is the small intestine, larval migration can lead to lung involvement in some cases.
4. Amebic lung disease: This is a rare complication of amebiasis, which is caused by the protozoan Entamoeba histolytica. The parasite usually infects the large intestine, but it can spread to other organs, including the lungs, through the bloodstream.
5. Cryptosporidiosis: This is a waterborne protozoan infection caused by Cryptosporidium parvum or C. hominis. Although the primary site of infection is the small intestine, immunocompromised individuals can develop disseminated disease, including pulmonary involvement.

Symptoms of parasitic lung diseases vary depending on the specific organism and the severity of infection but may include cough, chest pain, shortness of breath, fever, and sputum production. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, such as stool or blood examinations for parasites or their antigens. Treatment depends on the specific organism but may include antiparasitic medications, supportive care, and management of complications.

Chylous ascites is a medical condition characterized by the accumulation of milky, fat-containing fluid in the peritoneal cavity, which is the space within the abdomen that contains the intestines, liver, and other organs. The fluid, called chyle, is normally found in the lymphatic system and is formed when dietary fats are absorbed from the small intestine.

Chylous ascites can occur as a result of damage to the lymphatic vessels that transport chyle from the intestines to the bloodstream. This damage can be caused by various conditions, such as trauma, surgery, tumors, inflammation, or congenital abnormalities. When the lymphatic vessels are damaged, chyle leaks into the peritoneal cavity and accumulates there, leading to ascites.

Symptoms of chylous ascites may include abdominal distension, pain, nausea, vomiting, and weight loss. The condition can be diagnosed through various tests, such as imaging studies or analysis of the fluid in the peritoneal cavity. Treatment typically involves addressing the underlying cause of the condition, as well as managing symptoms and preventing complications. This may include dietary modifications, medications to reduce lymphatic flow, or surgical interventions to repair damaged lymphatic vessels.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Ascitic fluid is defined as the abnormal accumulation of fluid in the peritoneal cavity, which is the space between the two layers of the peritoneum, a serous membrane that lines the abdominal cavity and covers the abdominal organs. This buildup of fluid, also known as ascites, can be caused by various medical conditions such as liver cirrhosis, cancer, heart failure, or infection. The fluid itself is typically straw-colored and clear, but it may also contain cells, proteins, and other substances depending on the underlying cause. Analysis of ascitic fluid can help doctors diagnose and manage the underlying condition causing the accumulation of fluid.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

A fistula is an abnormal connection or passage between two organs, vessels, or body parts that usually do not connect. It can form as a result of injury, infection, surgery, or disease. A fistula can occur anywhere in the body but commonly forms in the digestive system, genital area, or urinary system. The symptoms and treatment options for a fistula depend on its location and underlying cause.

Pneumothorax is a medical condition that refers to the presence of air in the pleural space, which is the potential space between the lungs and the chest wall. This collection of air can result in a partial or complete collapse of the lung. The symptoms of pneumothorax may include sudden chest pain, shortness of breath, cough, and rapid heartbeat.

The two main types of pneumothorax are spontaneous pneumothorax, which occurs without any apparent cause or underlying lung disease, and secondary pneumothorax, which is caused by an underlying lung condition such as chronic obstructive pulmonary disease (COPD), asthma, or lung cancer.

Treatment for pneumothorax may include observation, oxygen therapy, needle aspiration, or chest tube insertion to remove the excess air from the pleural space and allow the lung to re-expand. In severe cases, surgery may be required to prevent recurrence.

A subdural effusion is an abnormal accumulation of fluid in the potential space between the dura mater (the outermost layer of the meninges that covers the brain and spinal cord) and the arachnoid membrane (one of the three layers of the meninges that surround the brain and spinal cord) in the subdural space.

Subdural effusions can occur due to various reasons, including head trauma, infection, or complications from neurosurgical procedures. The fluid accumulation may result from bleeding (subdural hematoma), inflammation, or increased cerebrospinal fluid pressure. Depending on the underlying cause and the amount of fluid accumulated, subdural effusions can cause various symptoms, such as headaches, altered mental status, or neurological deficits.

Subdural effusions are often asymptomatic and may resolve independently; however, in some cases, medical intervention might be necessary to alleviate the pressure on the brain or address the underlying condition. Imaging techniques like computed tomography (CT) or magnetic resonance imaging (MRI) scans are typically used to diagnose and monitor subdural effusions.

Pulmonary tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs and can spread to other parts of the body through the bloodstream or lymphatic system. The infection typically enters the body when a person inhales droplets containing the bacteria, which are released into the air when an infected person coughs, sneezes, or talks.

The symptoms of pulmonary TB can vary but often include:

* Persistent cough that lasts for more than three weeks and may produce phlegm or blood-tinged sputum
* Chest pain or discomfort, particularly when breathing deeply or coughing
* Fatigue and weakness
* Unexplained weight loss
* Fever and night sweats
* Loss of appetite

Pulmonary TB can cause serious complications if left untreated, including damage to the lungs, respiratory failure, and spread of the infection to other parts of the body. Treatment typically involves a course of antibiotics that can last several months, and it is essential for patients to complete the full treatment regimen to ensure that the infection is fully eradicated.

Preventive measures include vaccination with the Bacillus Calmette-Guérin (BCG) vaccine, which can provide some protection against severe forms of TB in children, and measures to prevent the spread of the disease, such as covering the mouth and nose when coughing or sneezing, wearing a mask in public places, and avoiding close contact with people who have active TB.

Thoracic surgery, video-assisted (VATS) is a minimally invasive surgical technique used to diagnose and treat various conditions related to the chest cavity, including the lungs, pleura, mediastinum, esophagus, and diaphragm. In VATS, a thoracoscope, a type of endoscope with a camera and light source, is inserted through small incisions in the chest wall to provide visualization of the internal structures. The surgeon then uses specialized instruments to perform the necessary surgical procedures, such as biopsies, lung resections, or esophageal repairs. Compared to traditional open thoracic surgery, VATS typically results in less postoperative pain, shorter hospital stays, and quicker recoveries for patients.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Pulmonary atelectasis is a medical condition characterized by the collapse or closure of the alveoli (tiny air sacs) in the lungs, leading to reduced or absent gas exchange in the affected area. This results in decreased lung volume and can cause hypoxemia (low oxygen levels in the blood). Atelectasis can be caused by various factors such as obstruction of the airways, surfactant deficiency, pneumothorax, or compression from outside the lung. It can also occur after surgical procedures, particularly when the patient is lying in one position for a long time. Symptoms may include shortness of breath, cough, and chest discomfort, but sometimes it may not cause any symptoms, especially if only a small area of the lung is affected. Treatment depends on the underlying cause and may include bronchodilators, chest physiotherapy, or even surgery in severe cases.

"Paragonimus" is a genus of lung flukes, which are parasitic flatworms that infect the lungs of humans and other mammals. The most common species that infect humans is Paragonimus westermani, also known as the oriental lung fluke.

Humans become infected with these parasites by eating raw or undercooked freshwater crustaceans (such as crabs or crayfish) that harbor the larval stage of the fluke. Once ingested, the larvae migrate from the intestines to the lungs, where they develop into adults and produce eggs. These eggs are coughed up and swallowed, and then passed in the feces. If the eggs reach fresh water, they hatch into miracidia, which infect snails, the first intermediate host.

Inside the snail, the parasites multiply asexually, and then emerge as cercariae, which encyst on the surface of crustaceans. When a human or another mammalian host eats the infected crustacean, the life cycle continues.

Paragonimiasis, the disease caused by Paragonimus infection, can lead to symptoms such as cough, chest pain, fever, and shortness of breath. In severe cases, it can cause lung damage and other complications.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Pneumonia is an infection or inflammation of the alveoli (tiny air sacs) in one or both lungs. It's often caused by bacteria, viruses, or fungi. Accumulated pus and fluid in these air sacs make it difficult to breathe, which can lead to coughing, chest pain, fever, and difficulty breathing. The severity of symptoms can vary from mild to life-threatening, depending on the underlying cause, the patient's overall health, and age. Pneumonia is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood tests. Treatment usually involves antibiotics for bacterial pneumonia, antivirals for viral pneumonia, and supportive care like oxygen therapy, hydration, and rest.

Pericardiectomy is a surgical procedure that involves the removal of all or part of the pericardium, which is the sac-like membrane surrounding the heart. This surgery is typically performed to treat chronic or recurrent pericarditis, constrictive pericarditis, or pericardial effusions that do not respond to other treatments. Pericardiectomy can help reduce symptoms such as chest pain, shortness of breath, and fluid buildup around the heart, improving the patient's quality of life and overall prognosis.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

In medical terms, percussion is a diagnostic procedure in which the edge of a solid object (usually the finger or a small rubber hammer) is used to quickly and sharply strike the surface of the body, producing a sound that can help determine the size, shape, and density of underlying organs and structures. The resulting sound waves travel through the body and are interpreted by the practitioner to make assessments about the condition of the patient's internal organs.

Percussion is often used in conjunction with other diagnostic techniques, such as auscultation (listening to bodily sounds) and palpation (feeling the body for abnormalities), to help form a complete picture of a patient's health. It is commonly used to assess the size and position of the lungs, heart, liver, spleen, and other organs, as well as to identify any fluid or air accumulations in the body.

Percussion is a valuable tool in physical examinations and can help healthcare providers make informed decisions about patient care. However, it requires practice and skill to perform accurately, and should be used in conjunction with other diagnostic techniques for best results.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Keratin-19 is a type I acidic keratin that is primarily expressed in simple epithelia, such as the gastrointestinal tract, respiratory tract, and epidermal appendages (e.g., hair follicles, sweat glands). It plays an essential role in maintaining the structure and integrity of these tissues by forming intermediate filaments that provide mechanical support to cells.

Keratin-19 is often used as a marker for simple epithelial differentiation and has been implicated in various pathological conditions, including cancer progression and metastasis. Mutations in the KRT19 gene, which encodes keratin-19, have been associated with certain genetic disorders, such as epidermolysis bullosa simplex, a blistering skin disorder.

In summary, Keratin-19 is an important structural protein expressed in simple epithelia that plays a crucial role in maintaining tissue integrity and has implications in various pathological conditions.

Instillation, in the context of drug administration, refers to the process of introducing a medication or therapeutic agent into a body cavity or onto a mucous membrane surface using gentle, steady pressure. This is typically done with the help of a device such as an eyedropper, pipette, or catheter. The goal is to ensure that the drug is distributed evenly over the surface or absorbed through the mucous membrane for localized or systemic effects. Instillation can be used for various routes of administration including ocular (eye), nasal, auricular (ear), vaginal, and intra-articular (joint space) among others. The choice of instillation as a route of administration depends on the drug's properties, the desired therapeutic effect, and the patient's overall health status.

A pancreatic fistula is an abnormal connection or passage between the pancreas and another organ, often the digestive system. It usually occurs as a complication following trauma, surgery, or inflammation of the pancreas (such as pancreatitis). The pancreas secretes digestive enzymes, and when these enzymes escape the pancreas through a damaged or disrupted duct, they can cause irritation and inflammation in nearby tissues, leading to the formation of a fistula.

Pancreatic fistulas are typically characterized by the drainage of pancreatic fluid, which contains high levels of digestive enzymes, into other parts of the body. This can lead to various symptoms, including abdominal pain, swelling, fever, and malnutrition. Treatment may involve surgical repair of the fistula, as well as supportive care such as antibiotics, nutritional support, and drainage of any fluid collections.

Cytodiagnosis is the rapid, initial evaluation and diagnosis of a disease based on the examination of individual cells obtained from a body fluid or tissue sample. This technique is often used in cytopathology to investigate abnormalities such as lumps, bumps, or growths that may be caused by cancerous or benign conditions.

The process involves collecting cells through various methods like fine-needle aspiration (FNA), body fluids such as urine, sputum, or washings from the respiratory, gastrointestinal, or genitourinary tracts. The collected sample is then spread onto a microscope slide, stained, and examined under a microscope for abnormalities in cell size, shape, structure, and organization.

Cytodiagnosis can provide crucial information to guide further diagnostic procedures and treatment plans. It is often used as an initial screening tool due to its speed, simplicity, and cost-effectiveness compared to traditional histopathological methods that require tissue biopsy and more extensive processing. However, cytodiagnosis may not always be able to distinguish between benign and malignant conditions definitively; therefore, additional tests or follow-up evaluations might be necessary for a conclusive diagnosis.

Auscultation is a medical procedure in which a healthcare professional uses a stethoscope to listen to the internal sounds of the body, such as heart, lung, or abdominal sounds. These sounds can provide important clues about a person's health and help diagnose various medical conditions, such as heart valve problems, lung infections, or digestive issues.

During auscultation, the healthcare professional places the stethoscope on different parts of the body and listens for any abnormal sounds, such as murmurs, rubs, or wheezes. They may also ask the person to perform certain movements, such as breathing deeply or coughing, to help identify any changes in the sounds.

Auscultation is a simple, non-invasive procedure that can provide valuable information about a person's health. It is an essential part of a physical examination and is routinely performed by healthcare professionals during regular checkups and hospital visits.

A Receiver Operating Characteristic (ROC) curve is a graphical representation used in medical decision-making and statistical analysis to illustrate the performance of a binary classifier system, such as a diagnostic test or a machine learning algorithm. It's a plot that shows the tradeoff between the true positive rate (sensitivity) and the false positive rate (1 - specificity) for different threshold settings.

The x-axis of an ROC curve represents the false positive rate (the proportion of negative cases incorrectly classified as positive), while the y-axis represents the true positive rate (the proportion of positive cases correctly classified as positive). Each point on the curve corresponds to a specific decision threshold, with higher points indicating better performance.

The area under the ROC curve (AUC) is a commonly used summary measure that reflects the overall performance of the classifier. An AUC value of 1 indicates perfect discrimination between positive and negative cases, while an AUC value of 0.5 suggests that the classifier performs no better than chance.

ROC curves are widely used in healthcare to evaluate diagnostic tests, predictive models, and screening tools for various medical conditions, helping clinicians make informed decisions about patient care based on the balance between sensitivity and specificity.

Eosinophilia is a medical condition characterized by an abnormally high concentration of eosinophils in the circulating blood. Eosinophils are a type of white blood cell that play an important role in the immune system, particularly in fighting off parasitic infections and regulating allergic reactions. However, when their numbers become excessively high, they can contribute to tissue damage and inflammation.

Eosinophilia is typically defined as a count of more than 500 eosinophils per microliter of blood. Mild eosinophilia (up to 1,500 cells/μL) may not cause any symptoms and may be discovered during routine blood tests. However, higher levels of eosinophilia can lead to various symptoms such as coughing, wheezing, skin rashes, and organ damage, depending on the underlying cause.

The causes of eosinophilia are varied and can include allergic reactions, parasitic infections, autoimmune disorders, certain medications, and some types of cancer. Accurate diagnosis and treatment of eosinophilia require identification and management of the underlying cause.

Medical Definition of "Herpesvirus 8, Human" (HHV-8):

Human Herpesvirus 8 (HHV-8), also known as Kaposi's Sarcoma-associated Herpesvirus (KSHV), is a DNA virus from the family of Herpesviridae. It is the causative agent of several malignancies, including Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD). HHV-8 is primarily transmitted through saliva, sexual contact, or organ transplantation. In immunocompromised individuals, such as those with HIV/AIDS, the risk of HHV-8-associated malignancies significantly increases. The virus establishes latency in infected cells and can periodically reactivate, causing inflammation and potentially leading to the development of cancer.

Adenocarcinoma is a type of cancer that arises from glandular epithelial cells. These cells line the inside of many internal organs, including the breasts, prostate, colon, and lungs. Adenocarcinomas can occur in any of these organs, as well as in other locations where glands are present.

The term "adenocarcinoma" is used to describe a cancer that has features of glandular tissue, such as mucus-secreting cells or cells that produce hormones. These cancers often form glandular structures within the tumor mass and may produce mucus or other substances.

Adenocarcinomas are typically slow-growing and tend to spread (metastasize) to other parts of the body through the lymphatic system or bloodstream. They can be treated with surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these treatments. The prognosis for adenocarcinoma depends on several factors, including the location and stage of the cancer, as well as the patient's overall health and age.

Middle ear ventilation refers to the normal process of air movement between the middle ear and the back of the nose (nasopharynx) through the eustachian tube. This tube is a narrow canal that connects the middle ear to the nasopharynx and helps to regulate air pressure in the middle ear, preventing its accumulation and subsequent negative pressure or fluid build-up, which can lead to conditions such as otitis media (middle ear infection) or serous otitis media (fluid in the middle ear).

The eustachian tube opens during activities such as swallowing, yawning, or chewing, allowing fresh air to enter the middle ear and any accumulated fluid or gas to be drained out. Abnormalities in middle ear ventilation can result from dysfunction of the eustachian tube, leading to various middle ear disorders.

... at distinguishing malignant pleural effusions from other causes of pleural effusion, based on the presence of visible pleural ... Identification of pleural fluid biomarkers to distinguish malignant pleural effusions from other causes of exudative effusions ... Malignant pleural effusions are exudates. A low pleural fluid pH is associated with poorer survival and reduced pleurodesis ... Lung cancer and breast cancer account for about 50-65% of malignant pleural effusions. Other common causes include pleural ...
... catheters is an effective way to treat patients with a malignant pleural effusion on an outpatient basis with a high degree of ... Management of malignant pleural effusions using the Pleur(x) catheter Ann Thorac Surg. 2008 Mar;85(3):1049-55. doi: 10.1016/j. ... Background: A malignant pleural effusion can cause significant morbidity to terminal patients. Drainage and control of the ... Conclusions: Insertion of Pleur(x) catheters is an effective way to treat patients with a malignant pleural effusion on an ...
... Chest. 2011 Jun;139(6):1419-1423. doi: 10.1378/chest.10-1868. ... Background: Malignant pleural effusions (MPEs) affect , 150,000 people each year in the United States. Current palliative ... pleurodesis protocol by combining medical thoracoscopy with talc pleurodesis and simultaneous placement of a tunneled pleural ...
All patients received a definitive pleural intervention with 77.8% pleurodesis success at 6-months and majority of them ... All patients received a definitive pleural intervention with 77.8% pleurodesis s... ... and improvement in quality of life can be achieved with either talc pleurodesis or insertion of an indwelling tunneled pleural ... and improvement in quality of life can be achieved with either talc pleurodesis or insertion of an indwelling tunnelled pleural ...
Malignant pleural effusion (MPE) is a common clinical problem, affecting around 15% of those with cancer,1 equating to at least ... Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev 2016;8: ... Optimal management of symptomatic malignant pleural effusions remains an important issue as it affects a significant number of ... This paper summarises the results of the recently published Cochrane review on interventions in malignant pleural effusions. ...
The ERS-education website provides centralised access to all educational material produced by the European Respiratory Society. It is the worlds largest CME collection for lung diseases and treatment offering high quality e-learning and teaching resources for respiratory specialists. This distance learning portal contains up-to-date study material for the state-of-the-art in Pulmonology.
... intercostal catheters may be used for bedside pleurodesis in patients with malignant pleural effusions. ,small,Last reviewed ... What is the optimal management of malignant pleural effusions?. Introduction. Malignant pleural effusion (MPE) is a common ... Tunneled Pleural Catheter for the Treatment of Malignant Pleural Effusion: A Systematic Review and Meta-analysis. Am J Ther ... Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion. Clin Lung ...
Pleural disorders include pleurisy, pleural effusion and pneumothorax. Learn more. ... Malignant Pleural Effusion (National Cancer Institute) Also in Spanish * Pleurisy (Pleuritis) (American Academy of Family ... ClinicalTrials.gov: Pleural Diseases (National Institutes of Health) * ClinicalTrials.gov: Pleural Effusion (National ... The most common cause of pleural effusion is congestive heart failure. Lung diseases, like COPD, tuberculosis, and acute lung ...
... is an abnormal collection of fluid in the pleural space. Pleural effusion develops because of excessive filtration or defective ... Pleural effusion, which in pediatric patients most commonly results from an infection, ... Management of pleural effusions in children with malignant lymphoma. J Pediatr Surg. 1999 Apr. 34(4):635-8. [QxMD MEDLINE Link] ... Lateral view in a child with right-sided pleural effusion reveals a pleural effusion and a fluid level. ...
Malignant Pleural Effusion. Bleomycin is effective as a sclerosing agent for the treatment of malignant pleural effusion and ... Malignant Pleural Effusion. The safety and efficacy of bleomycin 60 units and tetracycline (1 g) as treatment for malignant ... When administered into the pleural cavity in the treatment of malignant pleural effusion, bleomycin acts as a sclerosing agent. ... Malignant Pleural Effusion-60 units administered as a single dose bolus intrapleural injection (see Administration: ...
Malignant pleural effusion is common clinical entity affecting 40,000 people per year in the UK. It can occur with primary ... Malignant pleural effusion (MPE) is defined by malignant cells within the pleural space. The pleural space can be involved by ... Signs of malignant pleural effusion on CT include pleural thickening, nodular pleural thickening, mediastinal pleural ... Malignant pleural effusion (MPE) is a common clinical entity affecting 40,000 people per year in the UK. Malignant pleural ...
Thoracic computed tomography scans and ultrasound are helpful in distinguishing malignant from benign effusions. Pleural fluid ... Previously, first-line treatment for recurrent symptomatic malignant pleural effusion was chest drain insertion and talc ... It usually presents with dyspnea and a unilateral large pleural effusion. ... In cytology-negative disease, pleural biopsies are helpful. Current management is palliative. ...
Malignant pleural effusion (MPE) is the second most common cause of pleural exudate and affects 15% of all patients with cancer ... 2. Management of Malignant Pleural Effusion A small percentage of patients with MPE remain asymptomatic and hence can be ... Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am. J. Respir. Crit. Care Med. ... Predicting survival in malignant pleural effusion: Development and validation of the LENT prognostic score. Thorax 2014, 69, ...
SURVIVAL AND PLEURODESIS OUTCOME IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION - POST-HOC ANALYSIS FROM THE TIME-1 TRIAL Share ... SURVIVAL AND PLEURODESIS OUTCOME IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION - POST-HOC ANALYSIS FROM THE TIME-1 TRIAL ...
Papillary thyroid carcinoma is an uncommon cause of malignant pleural effusion, with only 10 cases reported in the literature, ... Such a characteristic may be useful in expediting diagnosis of a malignant pleural effusion in the appropriate clinical context ... right-sided pleural effusion and a 83-fold higher pleural thyroglobulin level compared to corresponding serum, supporting this ... We describe for the first time a distinctive brown colour of the malignant effusion (despite centrifugation) from a rare case ...
Malignant pleural effusions associated with non-small cell lung cancer and malignant pleural mesothelioma is factor in ... malignant pleural effusions, benign effusions and the published plasma profile of patients receiving chimeric antigen receptor ... Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic ... Filed Under: Mesothelioma Tagged With: lung cancer, malignant mesothelioma, malignant pleural mesothelioma (MPM), mesothelioma ...
Benign and Malignant Pleural Effusions answers are found in the Pearsons General Thoracic powered by Unbound Medicine. ... "Benign and Malignant Pleural Effusions." Pearsons General Thoracic Surgery. STS Cardiothoracic Surgery E-Book, Chicago: ... Benign and Malignant Pleural Effusions. In: Darling GE, Baumgartner WA, Jacobs JP, eds. Pearsons General Thoracic Surgery. STS ... Benign and Malignant Pleural Effusions [Internet]. In: Darling GE, Baumgartner WA, Jacobs JP, editors. Pearsons General ...
We use cookies to ensure that we give you the best experience on our website. If you click Accept all cookies well assume that you are happy to receive all cookies and you wont see this message again. If you click Reject all non-essential cookies only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click Find out more for information on how to change your cookie settings. ...
Home » How to treat malignant pleural effusion of lung cancer. How to treat malignant pleural effusion of lung cancer. By Dr. ... How to treat malignant pleural effusion of lung cancer? Once diagnosed with malignant pleural effusion that should be actively ... Some small cell lung cancer patients with chemotherapy can also be controlled by pleural effusion. Refractory pleural effusion ... causing inflammation stimulate the formation of pleural adhesions.. How to treat malignant pleural effusion of lung cancer (3) ...
Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. / Katayama, Hideki; Hiraki, ... Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. International Journal of Cancer ... Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. In: International Journal of ... In samples from 47 patients with malignant pleural effusions and 34 with nonmalignant effusions, we used a methylation-specific ...
Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion ... Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion ...
... tuberculous and malignant effusions. We studied 124 patients with pleural effusions, classified as exudates [total (n=97), ... Pleural fluid CRP was higher in parapneumonic compared to tuberculous and malignant effusions, providing 100% sensitivity for a ... Acute phase markers for the differentiation of infectious and malignant pleural effusions. ... IL-6 was higher in both parapneumonic and tuberculous compared to malignant effusions. TNF-α was higher in tuberculous compared ...
N2 - Patients with malignant pleural effusion (MPE) who underwent successful pleurodesis survive longer than those for whom it ... AB - Patients with malignant pleural effusion (MPE) who underwent successful pleurodesis survive longer than those for whom it ... Patients with malignant pleural effusion (MPE) who underwent successful pleurodesis survive longer than those for whom it fails ... abstract = "Patients with malignant pleural effusion (MPE) who underwent successful pleurodesis survive longer than those for ...
Interventions for the management of malignant pleural effusions: a network meta‐analysis answers are found in the Cochrane ... "Interventions for the Management of Malignant Pleural Effusions: a Network Meta‐analysis." Cochrane Abstracts, Evidence Central ... Interventions for the Management of Malignant Pleural Effusions: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. [ ... TY - ELEC T1 - Interventions for the management of malignant pleural effusions: a network meta‐analysis ID - 435294 BT - ...
Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion Share Share Share ... Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion ...
Malignant pleural effusion dosing for Sclerosol (talc powder, sterile) frequency-based adverse effects, comprehensive ... Malignant Pleural Effusion. Indicated as a sclerosing agent to decrease malignant pleural effusion recurrence in symptomatic ... thereby obliterating the pleural space and preventing reaccumulation of pleural fluid ... Administered intrapleurally via chest tube after adequate drainage of the effusion. Aerosol : 4-8 g (1-2 canisters); deliver by ...
Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. / Yeung, Maggie; Loh, El ... Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. Clinical and Experimental ... 深入研究「Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis」主題。共同形成了獨特的指紋。 ... Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion : a meta-analysis. 於: Clinical and ...
Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of ... Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centres ten years of experience by ... Pleural Catheters and Chemical Pleurodesis Through Tube Thoracostomy for the Management of Malignant Pleural Effusions by: ... Pleural Catheters and Chemical Pleurodesis Through Tube Thoracostomy for the Management of Malignant Pleural Effusions by: ...
Patients with cytologically or histopathologically proven pleural carcinosis and malignant pleural effusion, hospitalized at ... Objectives: The aim of the presented study was to analyze clinical data of patients with symptomatic malignant pleural effusion ... Comparison of outcomes of surgical and other invasive treatment modalities for malignant pleural effusion in patients with ... Schramm, J. (2022). Comparison of outcomes of surgical and other invasive treatment modalities for malignant pleural effusion ...

No FAQ available that match "pleural effusion malignant"

No images available that match "pleural effusion malignant"